Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × xentuzumab × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

INDUSTRY 6 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

Cyclophosphamide 1819 Radiotherapy 1778 Cisplatin 1611 Carboplatin 1370 Gemcitabine 1271 Paclitaxel 1168 Bevacizumab 1150 pembrolizumab 1094 Docetaxel 1093 Capecitabine 1048 Oxaliplatin 1045 Fluorouracil 976 Dexamethasone 870 Magnetic Resonance Spectroscopy 859 Nivolumab 829 Rituximab 823 Drug Therapy 789 Surveys and Questionnaires 785 Doxorubicin 749 Etoposide 740 Blood Specimen Collection 719 Radiosurgery 715 Irinotecan 700 Cytarabine 657 fludarabine 637 Leucovorin 617 Surgical Procedures, Operative 562 Lenalidomide 556 Biopsy 522 Radiation 513

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05110495 2025-02-17

WINGMEN

University of Oxford

Phase EARLY_PHASE1 Completed

27 enrolled 9 charts

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡